|Bid||0.00 x 800|
|Ask||6.50 x 1000|
|Day's Range||5.75 - 5.85|
|52 Week Range||5.60 - 8.68|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.72 (12.37%)|
|Ex-Dividend Date||Apr 02, 2018|
|1y Target Est||N/A|
SCOTTSDALE, Ariz., June 15, 2022--Voya Investment Management, the asset management business of Voya Financial, Inc. (NYSE: VOYA), announced today the distributions on the common shares of three of its closed-end funds (each a "Fund" and collectively, the "Funds").
Pharmaceutical Industry Veteran Brings Broad Legal Expertise to Vaxart Senior Management Team SOUTH SAN FRANCISCO, Calif., Feb. 14, 2022 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced the appointment of Edward B. Berg as the Company's first in-house General Counsel, effective today. Mr. Berg has practiced law for more than 30 years and has represented Fortune 500 and mid-cap companies in biotechnology, pharmaceuticals and life sciences. He joins Vaxart from BioMarin Pharmaceutic
Vaxart, Inc. ( NASDAQ:VXRT ) is possibly approaching a major achievement in its business, so we would like to shine...